MENU
+Compare
BHC
Stock ticker: NYSE
AS OF
Jan 17 closing price
Price
$7.44
Change
-$0.21 (-2.75%)
Capitalization
3.86B

BHC Bausch Health Companies Forecast, Technical & Fundamental Analysis

a manufacturer of pharmaceutical products

BHC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for BHC with price predictions
Jan 08, 2025

Momentum Indicator for BHC turns positive, indicating new upward trend

BHC saw its Momentum Indicator move above the 0 level on December 31, 2024. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 79 similar instances where the indicator turned positive. In of the 79 cases, the stock moved higher in the following days. The odds of a move higher are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for BHC just turned positive on December 30, 2024. Looking at past instances where BHC's MACD turned positive, the stock continued to rise in of 46 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where BHC advanced for three days, in of 284 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 58 cases where BHC's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BHC declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

BHC broke above its upper Bollinger Band on December 31, 2024. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for BHC entered a downward trend on December 23, 2024. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (58.527). P/E Ratio (13.387) is within average values for comparable stocks, (90.460). BHC's Projected Growth (PEG Ratio) (0.011) is slightly lower than the industry average of (2.947). Dividend Yield (0.000) settles around the average of (0.122) among similar stocks. P/S Ratio (0.433) is also within normal values, averaging (19.547).

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. BHC’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BHC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock worse than average.

View a ticker or compare two or three
BHC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

BHC is expected to report earnings to fall 586.96% to $1.12 per share on February 19

Bausch Health Companies BHC Stock Earnings Reports
Q4'24
Est.
$1.12
Q3'24
Missed
by $1.26
Q2'24
Beat
by $0.19
Q1'24
Missed
by $0.86
Q4'23
Beat
by $0.12
The last earnings report on October 30 showed earnings per share of -23 cents, missing the estimate of $1.03. With 3.77M shares outstanding, the current market capitalization sits at 3.86B.
A.I.Advisor
published Dividends

BHC paid dividends on December 22, 2010

Bausch Health Companies BHC Stock Dividends
А quarterly dividend of $1.00 per share was paid with a record date of December 22, 2010, and an ex-dividend date of November 10, 2010. Read more...
A.I. Advisor
published General Information

General Information

a manufacturer of pharmaceutical products

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
2150 Saint Elzear Boulvard West
Phone
+1 514 744-6792
Employees
20270
Web
https://www.bauschhealth.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RGACX74.410.84
+1.14%
American Funds Growth Fund of Amer R3
AFDAX53.670.45
+0.85%
American Century Large Cap Equity A
SUIIX48.220.18
+0.37%
DWS CROCI International Inst
PLARX11.51N/A
N/A
Principal SmallCap Value II R5
STCEX5.06N/A
N/A
Virtus Ceredex Small-Cap Value Eq C

BHC and Stocks

Correlation & Price change

A.I.dvisor tells us that BHC and HLN have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BHC and HLN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BHC
1D Price
Change %
BHC100%
-2.75%
HLN - BHC
25%
Poorly correlated
+0.54%
SUPN - BHC
24%
Poorly correlated
-0.34%
DVAX - BHC
23%
Poorly correlated
+0.48%
SNDL - BHC
23%
Poorly correlated
-1.11%
AMRX - BHC
23%
Poorly correlated
-0.60%
More